Vimarsana
Biggest News Aggregation in the World

Timothy Mcgraw News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Timothy Mcgraw. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Timothy Mcgraw Today - Breaking & Trending Today

Genetic signature may predict lung cancer response to immunotherapy - Vimarsana News

Genetic signature may predict lung cancer response to immunotherapy

A new study has identified a set of 140 genes that may help predict enhanced disease-free survival in patients with non-small-cell lung cancer treated with a combination of immunotherapy and low-dose radiation.

Philadelphians drop class action suit filed after Delaware River chemical spill - Vimarsana News

Philadelphians drop class action suit filed after Delaware River chemical spill

PHILADELPHIA – Three Philadelphians have opted to dismiss a class action lawsuit in connection with a March spill of thousands of gallons of a chemical used to refine latex, from a Bristol plant into a tributary of the Delaware River.

Philadelphians bring class action suit after Delaware River chemical spill - Vimarsana News

Philadelphians bring class action suit after Delaware River chemical spill

PHILADELPHIA – Three Philadelphians have brought a class action lawsuit in connection with a recent spill of thousands of gallons of a chemical used to refine latex, from a Bristol plant into a tributary of the Delaware River.

Researchers receive NIH grant to develop mRNA vaccines to deter cancer development - Vimarsana News

Researchers receive NIH grant to develop mRNA vaccines to deter cancer development

A multidisciplinary team of Weill Cornell Medicine researchers have received a five-year $5.7 million grant from the National Cancer Institute at the National Institutes of Health to fund a center aimed at developing messenger RNA (mRNA) vaccines to deter cancer development in at-risk groups.

Potential Therapeutic Target May Give Immunotherapy a Boost - Vimarsana News

Potential Therapeutic Target May Give Immunotherapy a Boost

Researchers are looking for ways to enhance the antitumor response. Now, researchers at Weill Cornell Medicine and Albert Einstein College of Medicine, report they have discovered tumors can use an enzyme called ART1 to thwart antitumor immune cells.